Peptide drug sector strengthens, Novartis hits the daily limit

MaticHoleFiller · 2026-03-26T22:19:04+00:00

March 26 News, the peptide drug sector performed strongly, with Minerva Pharmaceuticals' stock price hitting the daily limit. Investment should be cautious; this information is for reference only and does not constitute investment advice.

MaticHoleFiller

2026-03-26 22:19:04

Abstract generation in progress

As of 09:45 on March 26, the peptide drug sector strengthened, with Menovo (rights protection) hitting the daily limit up.

Disclaimer: The market carries risks; please invest cautiously. This article is automatically published based on data from third-party databases and does not represent Sina Finance’s views. Any information appearing in this article is for reference only and does not constitute personal investment advice. Please refer to official announcements for any discrepancies. If you have questions, contact biz@staff.sina.com.cn.

Massive information, precise analysis, all on Sina Finance APP

Editor: Xiao Lang Kuai Bao

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes